Aniruddha Rajurkar appointed as CEO of Zenex Animal Health
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
Subscribe To Our Newsletter & Stay Updated